Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

PF-3845 has antiallodynic effects in preclinical study

Aug. 6, 2010

TM-38837 shows favorable safety and pharmacokinetics in healthy subjects

Aug. 5, 2010

Japanese scientists identify potential biomarkers for coronary artery disease

Aug. 5, 2010

Candesartan inhibits fibrosis in rat model of RMI by suppressing sFRP-2

Aug. 5, 2010

TBR-652 exhibits potent anti-HIV activity in phase II trial

Aug. 4, 2010

Reduced TSPO expression and low progesterone are linked to MDD

Aug. 3, 2010

Promising preliminary phase II data disclosed on HIV immunotherapeutic AGS-004

Aug. 3, 2010

Suven Life Sciences presents new agents with encouraging in vivo procognitive activity

Aug. 3, 2010

Astaxanthin derivatives show promise in preclinical models of cardiovascular inflammation

Aug. 2, 2010

Sexual dysfunction in schizophrenia linked to typical antipsychotics, prolactin and DRD2 genotype

Aug. 2, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...